February 28, 2015 10:19 PM ET


Company Overview of Genentech, Inc.

Executive Profile

Marc Tessier-Lavigne Ph.D.

Director, Chairman of Compensation Committee and Member of Technology Committee, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 6 different industries.

See Board Relationships


Dr. Marc Tessier-Lavigne, Ph.D. has been the President of The Rockefeller University since 2011, where Dr. Tessier-Lavigne also serves as a professor and head of the laboratory of brain development and repair. He is a Co-founder of Renovis Inc. He joined The Rockefeller University in 2011. He served as the Chief Scientific Officer and Executive Vice President of Research of Genentech, Inc. He served as an Executive Vice President of Research Drug Discovery of Genentech ...

Corporate Headquarters

1 DNA Way
South San Francisco, California 94080-4990

United States

Phone: 650-225-1000
Fax: 650-225-6000

Board Members Memberships

Director, Chairman of Compensation Committee and Member of Technology Committee
Independent Director, Member of Regulatory & Compliance Committee, Member of Regulatory & Compliance Committee and Member of Science & Technology Committee
Director, Chairman of Compensation Committee and Chairman of Science & Technology Committee


Bachelor's Degree
McGill University
Bachelor's Degree
University of Oxford
Doctorate 1987
University College London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$75,000
Total Calculated Compensation$1,418,763

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Leonard Bell M.D.Co-Founder, Chairman of the Board and Chief Executive Officer
Alexion Pharmaceuticals, Inc.
Nobuo Hanai Ph.D.Chief Executive Officer, President and Representative Director
Kyowa Hakko Kirin Co., Ltd.
Jean-Christophe Tellier Chief Executive Officer and Director
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genentech, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.